{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:40:59Z","timestamp":1790638859914,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Vet Scand"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Foot-and-mouth disease (FMD) remains one of the most economically important infectious diseases of production animals. Six (out of 7 that have been identified) different serotypes of the FMD virus continue to circulate in different parts of the world. Within each serotype there is also extensive diversity as the virus constantly changes. Vaccines need to be \u201cmatched\u201d to the outbreak strain, not just to the serotype, to confer protection. Vaccination has been used successfully to assist in the eradication of the disease from Europe but is no longer employed there unless outbreaks occur. Thus the animal population in Europe, as in North America, is fully susceptible to the virus if it is accidentally (or deliberately) introduced. Almost 3 billion doses of the vaccine are made each year to control the disease elsewhere. Current vaccines are produced from chemically inactivated virus that has to be grown, on a large scale, under high containment conditions. The vaccine efficiently prevents disease but the duration of immunity is rather limited (about 6\u00a0months) and vaccination does not provide sterile immunity or block the development of carriers. Furthermore, the vaccine is quite unstable and a cold chain needs to be maintained to preserve the efficacy of the vaccine. This can be a challenge in the parts of the world where the disease is endemic. There is a significant interest in developing improved vaccines and significant progress in this direction has been made using a variety of approaches. However, no alternative vaccines are yet available commercially. Improved disease control globally is clearly beneficial to all countries as it reduces the risk of virus incursions into disease free areas.<\/jats:p>","DOI":"10.1186\/s13028-020-00519-1","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T12:03:04Z","timestamp":1589976184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Towards improvements in foot-and-mouth disease vaccine performance"],"prefix":"10.1186","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1187-4873","authenticated-orcid":false,"given":"Graham J.","family":"Belsham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"519_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9975(03)00041-0","volume":"129","author":"S Alexandersen","year":"2003","unstructured":"Alexandersen S, Zhang Z, Donaldson AI, Garland AJ. The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol. 2003;129:1\u201336.","journal-title":"J Comp Pathol"},{"key":"519_CR2","first-page":"9","volume":"288","author":"S Alexandersen","year":"2005","unstructured":"Alexandersen S, Mowat N. Foot-and-mouth disease: host range and pathogenesis. Curr Top Microbiol Immunol. 2005;288:9\u201342.","journal-title":"Curr Top Microbiol Immunol."},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1297-9716-44-116","volume":"44","author":"SM Jamal","year":"2013","unstructured":"Jamal SM, Belsham GJ. Foot-and-mouth disease: past, present and future. Vet Res. 2013;44:116. https:\/\/doi.org\/10.1186\/1297-9716-44-116.","journal-title":"Vet Res"},{"key":"519_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF01241895","volume":"23","author":"P Sutmoller","year":"1968","unstructured":"Sutmoller P, McVicar JW, Cottrall GE. The epizootiological importance of foot-and-mouth disease carriers. Arch Ges Virusforsch. 1968;23:227\u201335.","journal-title":"Arch Ges Virusforsch."},{"key":"519_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0007-1935(05)80168-X","volume":"149","author":"JS Salt","year":"1993","unstructured":"Salt JS. The carrier state in foot-and-mouth disease-an immunological review. Br Vet J. 1993;149:207\u201323.","journal-title":"Br Vet J"},{"key":"519_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268800051864","volume":"114","author":"EL Woodbury","year":"1995","unstructured":"Woodbury EL. A review of the possible mechanisms for the persistence of foot-and-mouth disease virus. Epidemiol Infect. 1995;114:1\u201313.","journal-title":"Epidemiol Infect"},{"key":"519_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1539-6924.2008.01020.x","volume":"28","author":"Tenzin","year":"2008","unstructured":"Tenzin, Dekker A, Vernooij H, Bouma A, Stegeman A. Rate of foot-and-mouth disease virus transmission by carriers quantified from experimental data. Risk Anal. 2008;28:303\u20139. https:\/\/doi.org\/10.1111\/j.1539-6924.2008.01020.x.","journal-title":"Risk Anal."},{"issue":"5","key":"519_CR8","doi-asserted-by":"publisher","first-page":"e00365","DOI":"10.1128\/msphere.00365-18","volume":"3","author":"J Arzt","year":"2018","unstructured":"Arzt J, Belsham GJ, Lohse L, B\u00f8tner A, Stenfeldt C. Transmission of foot-and-mouth disease from persistently infected carrier cattle to naive cattle via transfer of oropharyngeal fluid. mSphere. 2018;3(5):e00365\u2013418. https:\/\/doi.org\/10.1128\/msphere.00365-18.","journal-title":"mSphere."},{"key":"519_CR9","unstructured":"OIE. 2017. Foot-and-mouth disease, Colombia. http:\/\/www.oie.int\/wahis_2\/public\/wahid.php\/Reviewreport\/Review?reportid=24353."},{"key":"519_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","volume":"112","author":"TJ Knight-Jones","year":"2013","unstructured":"Knight-Jones TJ, Rushton J. The economic impacts of foot and mouth disease\u2014what are they, how big are they and where do they occur? Prev Vet Med. 2013;112:161\u201373. https:\/\/doi.org\/10.1016\/j.prevetmed.2013.07.013.","journal-title":"Prev Vet Med."},{"key":"519_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.20506\/rst.21.3.1351","volume":"21","author":"JM Scudamore","year":"2002","unstructured":"Scudamore JM, Harris DM. Control of foot-and-mouth disease: lessons from the experience of the outbreak in Great Britain in 2001. Rev Off Int Epizoot. 2002;21:699\u2013710.","journal-title":"Rev Off Int Epizoot."},{"key":"519_CR12","first-page":"1","volume-title":"Foot and mouth disease, current perspectives","author":"F Brown","year":"2004","unstructured":"Brown F. Stepping stones in foot-and-mouth research: a personal view. In: Sobrino F, Domingo E, editors. Foot and mouth disease, current perspectives. UK: Horizon Bioscience; 2004. p. 1\u201317."},{"key":"519_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1865-1682.2007.01012.x","volume":"55","author":"K de Clercq","year":"2008","unstructured":"de Clercq K, Goris N, Barnett PV, MacKay DK. FMD vaccines: reflections on quality aspects for applicability in European disease control policy. Transbound Emerg Dis. 2008;55:46\u201356. https:\/\/doi.org\/10.1111\/j.1865-1682.2007.01012.x.","journal-title":"Transbound Emerg Dis."},{"key":"519_CR14","first-page":"41","volume":"119","author":"FH Pluimers","year":"2004","unstructured":"Pluimers FH. Foot-and-mouth disease control using vaccination: the Dutch experience in 2001. Dev Biol. 2004;119:41\u20139.","journal-title":"Dev Biol"},{"key":"519_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/tbed.12373","volume":"64","author":"BP Brito","year":"2015","unstructured":"Brito BP, Rodriguez LL, Hammond JM, Pinto J, Perez AM. Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014. Transbound Emerg Dis. 2015;64:316\u201332. https:\/\/doi.org\/10.1111\/tbed.12373.","journal-title":"Transbound Emerg Dis."},{"key":"519_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1099\/0022-1317-82-3-609","volume":"82","author":"AR Samuel","year":"2001","unstructured":"Samuel AR, Knowles NJ. Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol. 2001;82:609\u201321.","journal-title":"J Gen Virol"},{"key":"519_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.20506\/rst.35.3.2565","volume":"35","author":"NJ Knowles","year":"2016","unstructured":"Knowles NJ, Wadsworth J, Bachanek-Bankowska K, King DP. VP1 sequencing protocol for foot and mouth disease virus molecular epidemiology. Rev Sci Technol. 2016;35:741\u201355.","journal-title":"Rev Sci Technol"},{"key":"519_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1865-1682.2007.01010.x","volume":"55","author":"JF Valarcher","year":"2008","unstructured":"Valarcher JF, Leforban Y, Rweyemamu M, Roeder PL, Gerbier G, Mackay DK, et al. Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. Transbound Emerg Dis. 2008;55:14\u201334.","journal-title":"Transbound Emerg Dis."},{"key":"519_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/327482a0","volume":"327","author":"M Chow","year":"1987","unstructured":"Chow M, Newman JF, Filman D, Hogle JM, Rowlands DJ, Brown F. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature. 1987;327:482\u20136.","journal-title":"Nature"},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.bi.57.070188.000441","volume":"57","author":"DA Towler","year":"1988","unstructured":"Towler DA, Gordon JI, Adams SP, Glaser L. The biology and enzymology of eukaryotic protein acylation. Ann Rev Biochem. 1988;57:69\u201399.","journal-title":"Ann Rev Biochem."},{"key":"519_CR21","doi-asserted-by":"publisher","first-page":"11591","DOI":"10.1128\/JVI.01863-13","volume":"87","author":"M Gullberg","year":"2013","unstructured":"Gullberg M, Polacek C, B\u00f8tner A, Belsham GJ. Processing of the VP1\/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of \u201cself-tagged\u201d particles. J Virol. 2013;87:11591\u2013603. https:\/\/doi.org\/10.1128\/JVI.01863-13.","journal-title":"J Virol"},{"key":"519_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/JVI.69.1.430-438.1995","volume":"69","author":"S Curry","year":"1995","unstructured":"Curry S, Abrams CC, Fry E, Crowther JC, Belsham GJ, Stuart DI, et al. Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J Virol. 1995;69:430\u20138.","journal-title":"J Virol"},{"key":"519_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1099\/vir.0.054122-0","volume":"94","author":"M Gullberg","year":"2013","unstructured":"Gullberg M, Muszynski B, Organtini LJ, Ashley RE, Hafenstein SL, Belsham GJ, et al. Assembly and characterization of foot-and-mouth disease virus empty capsid particles expressed within mammalian cells. J Gen Virol. 2013;94:1769\u201379. https:\/\/doi.org\/10.1099\/vir.0.054122-0.","journal-title":"J Gen Virol"},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF01317896","volume":"59","author":"MM Rweyemamu","year":"1979","unstructured":"Rweyemamu MM, Terry G, Pay TW. Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch Virol. 1979;59:69\u201379.","journal-title":"Arch Virol"},{"key":"519_CR25","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1099\/0022-1317-76-12-3089","volume":"76","author":"CC Abrams","year":"1995","unstructured":"Abrams CC, King AM, Belsham GJ. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J Gen Virol. 1995;76:3089\u201398.","journal-title":"J Gen Virol"},{"key":"519_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF01314726","volume":"73","author":"TR Doel","year":"1982","unstructured":"Doel TR, Chong WK. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch Virol. 1982;73:185\u201391. https:\/\/doi.org\/10.1007\/BF01314726.","journal-title":"Arch Virol"},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1016\/j.vaccine.2008.04.062","volume":"26","author":"M Yang","year":"2008","unstructured":"Yang M, Holland H, Clavijo A. Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture. Vaccine. 2008;26:3377\u201382. https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.062.","journal-title":"Vaccine."},{"key":"519_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3389\/fimmu.2017.00960","volume":"8","author":"MM Harmsen","year":"2017","unstructured":"Harmsen MM, Seago J, Perez E, Charleston B, Ebl\u00e9 PL, Dekker A. Isolation of single-domain antibody fragments that preferentially detect intact (146S) particles of foot-and-mouth disease virus for use in vaccine quality control. Front Immunol. 2017;8:960. https:\/\/doi.org\/10.3389\/fimmu.2017.00960.","journal-title":"Front Immunol."},{"key":"519_CR29","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1016\/j.vaccine.2006.04.050","volume":"24","author":"E Brocchi","year":"2006","unstructured":"Brocchi E, Bergmann IE, Dekker A, Paton DJ, Sammin DJ, Greiner M, et al. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine. 2006;24:6966\u201379. https:\/\/doi.org\/10.1016\/j.vaccine.2006.04.050.","journal-title":"Vaccine."},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1016\/j.vaccine.2006.06.032","volume":"24","author":"DJ Paton","year":"2006","unstructured":"Paton DJ, de Clercq K, Greiner M, Dekker A, Brocchi E, Bergmann I, et al. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine. 2006;24:6503\u201312. https:\/\/doi.org\/10.1016\/j.vaccine.2006.06.032.","journal-title":"Vaccine."},{"key":"519_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1099\/0022-1317-69-2-265","volume":"69","author":"GJ Belsham","year":"1988","unstructured":"Belsham GJ, Bostock CJ. Studies on the infectivity of foot-and-mouth disease virus RNA using microinjection. J Gen Virol. 1988;69:265\u201374.","journal-title":"J Gen Virol"},{"key":"519_CR32","doi-asserted-by":"publisher","first-page":"e14621","DOI":"10.1371\/journal.pone.0014621","volume":"6","author":"GJ Belsham","year":"2011","unstructured":"Belsham GJ, Jamal SM, Tj\u00f8rneh\u00f8j K, B\u00f8tner A. Rescue of foot-and-mouth disease viruses that are pathogenic for cattle from preserved viral RNA samples. PLoS ONE. 2011;6:e14621. https:\/\/doi.org\/10.1371\/journal.pone.0014621.","journal-title":"PLoS ONE"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1128\/JVI.01480-07","volume":"82","author":"D Dicara","year":"2008","unstructured":"Dicara D, Burman A, Clark S, Berryman S, Howard MJ, Hart IR, et al. Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol. 2008;82:1537\u201346.","journal-title":"J Virol"},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"8519","DOI":"10.1128\/JVI.79.13.8519-8534.2005","volume":"79","author":"S Berryman","year":"2005","unstructured":"Berryman S, Clark S, Monaghan P, Jackson T. Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus. J Virol. 2005;79:8519\u201334.","journal-title":"J Virol"},{"key":"519_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/j.1460-2075.1992.tb05150.x","volume":"11","author":"GJ Belsham","year":"1992","unstructured":"Belsham GJ. Dual initiation sites of protein synthesis on foot-and-mouth disease virus RNA are selected following internal entry and scanning of ribosomes in vivo. EMBO J. 1992;11:1105\u201310.","journal-title":"EMBO J"},{"key":"519_CR36","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1128\/JVI.79.12.7698-7706.2005","volume":"79","author":"A Nayak","year":"2005","unstructured":"Nayak A, Goodfellow IG, Belsham GJ. Factors required for the uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol. 2005;79:7698\u2013706.","journal-title":"J Virol"},{"key":"519_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21775\/9781910190517.02","volume-title":"Foot-and-mouth disease virus: current research and emerging trends","author":"E Martinez-Salas","year":"2017","unstructured":"Martinez-Salas E, Belsham GJ. Genome organization, translation and replication of foot-and-mouth disease virus RNA. In: Sobrino F, Domingo E, editors. Foot-and-mouth disease virus: current research and emerging trends. Norfolk: Caister Academic Press; 2017. p. 13\u201342."},{"key":"519_CR38","doi-asserted-by":"publisher","first-page":"197909","DOI":"10.1016\/j.virusres.2020.197909","volume":"281","author":"GJ Belsham","year":"2020","unstructured":"Belsham GJ, Kristensen T, Jackson T. Foot-and-mouth disease virus: prospects for using knowledge of virus biology to improve control of this continuing global threat. Virus Res. 2020;281:197909. https:\/\/doi.org\/10.1016\/j.virusres.2020.197909.","journal-title":"Virus Res"},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1099\/vir.0.19408-0","volume":"85","author":"P Monaghan","year":"2004","unstructured":"Monaghan P, Cook H, Jackson T, Ryan M, Wileman T. The ultrastructure of the developing replication site in foot-and-mouth disease virus-infected BHK-38 cells. J Gen Virol. 2004;85:933\u201346.","journal-title":"J Gen Virol"},{"key":"519_CR40","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1099\/jgv.0.000485","volume":"97","author":"S Berryman","year":"2016","unstructured":"Berryman S, Moffat K, Harak C, Lohmann V, Jackson T. Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases. J Gen Virol. 2016;97:1841\u201352. https:\/\/doi.org\/10.1099\/jgv.0.000485.","journal-title":"J Gen Virol"},{"key":"519_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.virusres.2004.11.004","volume":"107","author":"C Castro","year":"2005","unstructured":"Castro C, Arnold JJ, Cameron CE. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res. 2005;107:141\u20139.","journal-title":"Virus Res"},{"key":"519_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1128\/MMBR.05023-11","volume":"76","author":"E Domingo","year":"2012","unstructured":"Domingo E, Sheldon J, Perales C. Viral quasispecies evolution. Microbiol Mol Biol Rev. 2012;76:159\u2013216. https:\/\/doi.org\/10.1128\/MMBR.05023-11.","journal-title":"Microbiol Mol Biol Rev"},{"key":"519_CR43","doi-asserted-by":"publisher","first-page":"29531","DOI":"10.1074\/jbc.M114.592303","volume":"289","author":"VK Korboukh","year":"2014","unstructured":"Korboukh VK, Lee CA, Acevedo A, Vignuzzi M, Xiao Y, Arnold JJ, et al. RNA virus population diversity, an optimum for maximal fitness and virulence. J Biol Chem. 2014;289:29531\u201344. https:\/\/doi.org\/10.1074\/jbc.M114.592303.","journal-title":"J Biol Chem"},{"key":"519_CR44","doi-asserted-by":"publisher","first-page":"11274","DOI":"10.1128\/JVI.01236-06","volume":"80","author":"EM Cottam","year":"2006","unstructured":"Cottam EM, Haydon DT, Paton DJ, Gloster J, Wilesmith JW, Ferris NP, et al. Molecular epidemiology of the foot-and-mouth disease virus outbreak in the United Kingdom in 2001. J Virol. 2006;80:11274\u201382.","journal-title":"J Virol"},{"key":"519_CR45","doi-asserted-by":"publisher","first-page":"e49650","DOI":"10.1371\/journal.pone.0049650","volume":"7","author":"B Valdazo-Gonz\u00e1lez","year":"2012","unstructured":"Valdazo-Gonz\u00e1lez B, Polihronova L, Alexandrov T, Normann P, Knowles NJ, Hammond JM, et al. Reconstruction of the transmission history of RNA virus outbreaks using full genome sequences: foot-and-mouth disease virus in Bulgaria in 2011. PLoS ONE. 2012;7:e49650.","journal-title":"PLoS ONE"},{"key":"519_CR46","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1128\/JVI.79.10.6487-6504.2005","volume":"79","author":"C Carrillo","year":"2005","unstructured":"Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, et al. Comparative genomics of foot-and-mouth disease virus. J Virol. 2005;79:6487\u2013504.","journal-title":"J Virol"},{"key":"519_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0168-1702(02)00260-5","volume":"91","author":"NJ Knowles","year":"2003","unstructured":"Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003;91:65\u201380.","journal-title":"Virus Res"},{"key":"519_CR48","doi-asserted-by":"publisher","first-page":"e1007509","DOI":"10.1371\/journal.ppat.1007509","volume":"15","author":"T Kristensen","year":"2019","unstructured":"Kristensen T, Belsham GJ. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites. PLoS Pathog. 2019;15:e1007509.","journal-title":"PLoS Pathog"},{"key":"519_CR49","doi-asserted-by":"publisher","first-page":"11747","DOI":"10.1038\/s41598-019-48170-9","volume":"9","author":"T Kristensen","year":"2019","unstructured":"Kristensen T, Belsham GJ. Identification of plasticity and interactions of a highly conserved motif within a picornavirus capsid precursor required for virus infectivity. Sci Rep. 2019;9:11747. https:\/\/doi.org\/10.1038\/s41598-019-48170-9.","journal-title":"Sci Rep."},{"key":"519_CR50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0092-8674(86)90600-8","volume":"47","author":"K Kirkegaard","year":"1986","unstructured":"Kirkegaard K, Baltimore D. The mechanism of RNA recombination in poliovirus. Cell. 1986;47:433\u201343.","journal-title":"Cell"},{"key":"519_CR51","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.meegid.2011.09.015","volume":"11","author":"SM Jamal","year":"2011","unstructured":"Jamal SM, Ferrari G, Ahmed S, Normann P, Belsham GJ. Molecular characterization of serotype Asia-1 foot-and-mouth disease viruses in Pakistan and Afghanistan; emergence of a new genetic Group and evidence for a novel recombinant virus. Infect Genet Evol. 2011;11:2049\u201362.","journal-title":"Infect Genet Evol."},{"key":"519_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1099\/vir.0.82555-0","volume":"88","author":"AL Jackson","year":"2007","unstructured":"Jackson AL, O\u2019Neill H, Maree F, Blignaut B, Carrillo C, Rodriguez L, et al. Mosaic structure of foot-and-mouth disease virus genomes. J Gen Virol. 2007;88:487\u201392.","journal-title":"J Gen Virol"},{"key":"519_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1743-422X-7-199","volume":"7","author":"SN Balinda","year":"2010","unstructured":"Balinda SN, Siegismund HR, Muwanika VB, Sangula AK, Masembe C, Ayebazibwe C, et al. Phylogenetic analyses of the polyprotein coding sequences of serotype O foot-and-mouth disease viruses in East Africa: evidence for interserotypic\u00a0recombination. Virol J. 2010;7:199. https:\/\/doi.org\/10.1186\/1743-422X-7-199.","journal-title":"Virol J."},{"issue":"2","key":"519_CR54","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/tbed.13433","volume":"67","author":"SM Jamal","year":"2020","unstructured":"Jamal SM, Nazem Shirazi MH, Ozyoruk F, Parlak U, Normann P, Belsham GJ. Evidence for multiple recombination events within foot-and-mouth disease viruses circulating in West Eurasia. Transbound Emerg Dis. 2020;67(2):979\u201393.\u00a0https:\/\/doi.org\/10.1111\/tbed.13433.","journal-title":"Transbound Emerg Dis."},{"key":"519_CR55","doi-asserted-by":"publisher","first-page":"14693","DOI":"10.1038\/s41598-018-32693-8","volume":"8","author":"K Bachanek-Bankowska","year":"2018","unstructured":"Bachanek-Bankowska K, Di Nardo A, Wadsworth J, Mioulet V, Pezzoni G, Grazioli S, et al. Reconstructing the evolutionary history of pandemic foot-and-mouth disease viruses: the impact of recombination within the emerging O\/ME-SA\/Ind-2001 lineage. Sci Rep. 2018;8:14693. https:\/\/doi.org\/10.1038\/s41598-018-32693-8.","journal-title":"Sci Rep."},{"key":"519_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coviro.2017.11.013","volume":"28","author":"DJ Paton","year":"2018","unstructured":"Paton DJ, Gubbins S, King DP. Understanding the transmission of foot-and-mouth disease virus at different scales. Curr Opin Virol. 2018;28:85\u201391.","journal-title":"Curr Opin Virol."},{"key":"519_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fvets.2016.00041","volume":"3","author":"C Stenfeldt","year":"2016","unstructured":"Stenfeldt C, Diaz-San Segundo F, de Los Santos T, Rodriguez LL, Arzt J. The pathogenesis of foot-and-mouth disease in pigs. Front Vet Sci. 2016;3:41. https:\/\/doi.org\/10.3389\/fvets.2016.00041.","journal-title":"Front Vet Sci."},{"key":"519_CR58","doi-asserted-by":"publisher","first-page":"e1008235","DOI":"10.1371\/journal.ppat.1008235","volume":"16","author":"L Ferretti","year":"2020","unstructured":"Ferretti L, P\u00e9rez-Mart\u00edn E, Zhang F, Maree F, de Klerk-Lorist LM, van Schalkwykc L, et al. Pervasive within-host recombination and epistasis as major determinants of the molecular evolution of the foot-and-mouth disease virus capsid. PLoS Pathog. 2020;16:e1008235. https:\/\/doi.org\/10.1371\/journal.ppat.1008235.","journal-title":"PLoS Pathog"},{"key":"519_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/337709a0","volume":"337","author":"R Acharya","year":"1989","unstructured":"Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 \u00c5 resolution. Nature. 1989;337:709\u201316.","journal-title":"Nature"},{"key":"519_CR60","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1016\/j.vaccine.2019.07.102","volume":"37","author":"DJ Paton","year":"2019","unstructured":"Paton DJ, Reeve R, Capozzo AV, Ludi A. Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory. Vaccine. 2019;37:5515\u201324.","journal-title":"Vaccine."},{"key":"519_CR61","unstructured":"OIE. Foot-and-mouth disease. OIE Terr Man. 2017. Chapter 3.1.8:1\u201332."},{"key":"519_CR62","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1016\/j.vaccine.2017.10.029","volume":"35","author":"NA Lyons","year":"2017","unstructured":"Lyons NA, Ludi AB, Wilsden G, Hamblin P, Qasim IA, Gubbins S, et al. Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A\/ASIA\/G-VII viral lineage. Vaccine. 2017;35:6850\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.029.","journal-title":"Vaccine."},{"key":"519_CR63","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.vaccine.2018.12.064","volume":"37","author":"NA Lyons","year":"2019","unstructured":"Lyons NA, Knight-Jones TJD, Bartels C, Paton DJ, Ferrari G, Vermillion MS, et al. Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines. Vaccine. 2019;37:1007\u201315. https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.064.","journal-title":"Vaccine."},{"key":"519_CR64","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1099\/0022-1317-68-6-1637","volume":"68","author":"QC Xie","year":"1987","unstructured":"Xie QC, McCahon D, Crowther JR, Belsham GJ, McCullough KC. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol. 1987;68:1637\u201347. https:\/\/doi.org\/10.1099\/0022-1317-68-6-1637.","journal-title":"J Gen Virol"},{"key":"519_CR65","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1128\/JVI.62.6.2033-2040.1988","volume":"62","author":"E Pfaff","year":"1988","unstructured":"Pfaff E, Thiel HJ, Beck E, Strohmaier K, Schaller H. Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol. 1988;62:2033\u201340.","journal-title":"J Virol"},{"key":"519_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0042-6822(90)90269-W","volume":"179","author":"J Kitson","year":"1990","unstructured":"Kitson J, McCahon D, Belsham GJ. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology. 1990;179:26\u201334.","journal-title":"Virology"},{"key":"519_CR67","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1128\/JVI.62.8.2782-2789.1988","volume":"62","author":"AA Thomas","year":"1988","unstructured":"Thomas AA, Woortmeijer RJ, Puijk W, Barteling SJ. Antigenic sites on foot-and-mouth disease virus type A10. J Virol. 1988;62:2782\u20139.","journal-title":"J Virol"},{"key":"519_CR68","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1128\/JVI.63.5.2143-2151.1989","volume":"63","author":"B Baxt","year":"1989","unstructured":"Baxt B, Vakharia V, Moore DM, Franke AJ, Morgan DO. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol. 1989;63:2143\u201351.","journal-title":"J Virol"},{"key":"519_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-70-1-59","volume":"70","author":"C Bolwell","year":"1989","unstructured":"Bolwell C, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. J Gen Virol. 1989;70:59\u201368.","journal-title":"J Gen Virol"},{"key":"519_CR70","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1128\/JVI.68.3.1407-1417.1994","volume":"68","author":"MG Mateu","year":"1994","unstructured":"Mateu MG, Hern\u00e1ndez J, Mart\u00ednez MA, Feigelstock D, Lea S, P\u00e9rez JJ, et al. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol. 1994;68:1407\u201317.","journal-title":"J Virol"},{"key":"519_CR71","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1099\/vir.0.048249-0","volume":"94","author":"S Grazioli","year":"2013","unstructured":"Grazioli S, Fallacara F, Brocchi E. Mapping of antigenic sites of foot-and-mouth disease virus serotype Asia 1 and relationships with sites described in other serotypes. J Gen Virol. 2013;94:559\u201369. https:\/\/doi.org\/10.1099\/vir.0.048249-0.","journal-title":"J Gen Virol"},{"key":"519_CR72","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1099\/0022-1317-70-3-639","volume":"70","author":"D McCahon","year":"1989","unstructured":"McCahon D, Crowther JR, Belsham GJ, Kitson JD, Duchesne M, Have P, et al. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol. 1989;70:639\u201345.","journal-title":"J Gen Virol"},{"key":"519_CR73","doi-asserted-by":"publisher","first-page":"e0201853","DOI":"10.1371\/journal.pone.0201853","volume":"13","author":"G Shimmon","year":"2018","unstructured":"Shimmon G, Kotecha A, Ren J, Asfor AS, Newman J, Berryman S, et al. Generation and characterisation of recombinant FMDV antibodies: applications for advancing diagnostic and laboratory assays. PLoS ONE. 2018;13:e0201853. https:\/\/doi.org\/10.1371\/journal.pone.0201853.","journal-title":"PLoS ONE"},{"key":"519_CR74","doi-asserted-by":"publisher","first-page":"e1001027","DOI":"10.1371\/journal.pcbi.1001027","volume":"6","author":"R Reeve","year":"2010","unstructured":"Reeve R, Blignaut B, Esterhuysen JJ, Opperman P, Matthews L, Fry EE, et al. Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus. PLOS Comp Biol. 2010;6:e1001027.","journal-title":"PLOS Comp Biol."},{"key":"519_CR75","doi-asserted-by":"publisher","first-page":"e0159360","DOI":"10.1371\/journal.pone.0159360","volume":"11","author":"R Reeve","year":"2016","unstructured":"Reeve R, Borley DW, Maree FF, Upadhyaya S, Lukhwareni A, Esterhuysen JJ, et al. Tracking the antigenic evolution of foot-and-mouth disease virus. PLoS ONE. 2016;11:e0159360. https:\/\/doi.org\/10.1371\/journal.pone.0159360.","journal-title":"PLoS ONE"},{"key":"519_CR76","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/14760584.2018.1492378","volume":"17","author":"M Mahapatra","year":"2018","unstructured":"Mahapatra M, Parida S. Foot-and-mouth disease vaccine strain selection: current approaches and future perspectives. Expert Rev Vaccine. 2018;17:577\u201391.","journal-title":"Expert Rev Vaccine."},{"key":"519_CR77","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1016\/j.vaccine.2017.10.099","volume":"35","author":"M Mahapatra","year":"2017","unstructured":"Mahapatra M, Upadhyaya S, Aviso S, Babu A, Hutchings G, Parida S. Selection of vaccine strains for serotype\u00a0O\u00a0foot-and-mouth disease viruses (2007\u20132012) circulating in Southeast Asia, East Asia and Far East. Vaccine. 2017;35:7147\u201353.","journal-title":"Vaccine."},{"key":"519_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1051\/vetres:2008051","volume":"40","author":"SJ Cox","year":"2009","unstructured":"Cox SJ, Barnett PV. Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review. Vet Res. 2009;40:13. https:\/\/doi.org\/10.1051\/vetres:2008051.","journal-title":"Vet Res"},{"key":"519_CR79","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.vaccine.2009.12.065","volume":"28","author":"SJ Cox","year":"2010","unstructured":"Cox SJ, Carr BV, Parida S, Hamblin PA, Prentice H, Charleston B, et al. Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve. Vaccine. 2010;28:2318\u201322. https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.065.","journal-title":"Vaccine."},{"key":"519_CR80","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1586\/14760584.8.3.347","volume":"8","author":"S Parida","year":"2009","unstructured":"Parida S. Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev Vaccine. 2009;8:347\u201365. https:\/\/doi.org\/10.1586\/14760584.8.3.347.","journal-title":"Expert Rev Vaccine."},{"key":"519_CR81","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1016\/j.vaccine.2017.02.047","volume":"35","author":"E Fishbourne","year":"2017","unstructured":"Fishbourne E, Ludi AB, Wilsden G, Hamblin P, Statham B, Bin-Tarif A, et al. Efficacy of a high potency O1 Manisa foot-and-mouth disease vaccine in cattle against heterologous challenge with a field virus from the O\/ME-SA\/Ind-2001 lineage collected in North Africa. Vaccine. 2017;35:2761\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.047.","journal-title":"Vaccine."},{"key":"519_CR82","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1016\/j.vaccine.2017.07.102","volume":"35","author":"J Horsington","year":"2017","unstructured":"Horsington J, Perez CB, Maradei E, Novo SG, Gonzales JL, Singanallur NB, et al. Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O\/SKR\/2010 at 7 or 4\u00a0days post vaccination. Vaccine. 2017;35:5179\u201385. https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.102.","journal-title":"Vaccine."},{"key":"519_CR83","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","volume":"26","author":"KE Brehm","year":"2008","unstructured":"Brehm KE, Kumar N, Thulke HH, Haas B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine. 2008;26:1681\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2008.01.038.","journal-title":"Vaccine."},{"key":"519_CR84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/VAAT.S55351","volume":"7","author":"GJ Belsham","year":"2015","unstructured":"Belsham GJ, B\u00f8tner A. Use of recombinant capsid proteins in the development of a vaccine against foot-and-mouth disease virus (FMDV). Virus Adapt Treat. 2015;7:11\u201323. https:\/\/doi.org\/10.2147\/VAAT.S55351.","journal-title":"Virus Adapt Treat."},{"key":"519_CR85","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coviro.2018.02.005","volume":"29","author":"T de los Santos","year":"2018","unstructured":"de los Santos T, Diaz-San Segundo F, Rodriguez LL. The need for improved vaccines against foot-and-mouth disease. Curr Opin Virol. 2018;29:16\u201325. https:\/\/doi.org\/10.1016\/j.coviro.2018.02.005.","journal-title":"Curr Opin Virol."},{"key":"519_CR86","doi-asserted-by":"publisher","first-page":"333","DOI":"10.21775\/9781910190517.14","volume-title":"Foot-and-mouth disease virus: current research and emerging trends","author":"F Diaz-San Segundo","year":"2017","unstructured":"Diaz-San Segundo F, Medina GN, Grubman MJ, de los Santos T. Control of foot-and-mouth disease by using replication-defective human adenoviruses to deliver vaccines and biotherapeutics. In: Sobrino F, Domingo E, editors. Foot-and-mouth disease virus: current research and emerging trends. Norfolk: Caister Academic Press; 2017. p. 333\u201356."},{"key":"519_CR87","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jviromet.2012.11.011","volume":"187","author":"C Porta","year":"2013","unstructured":"Porta C, Xu X, Loureiro S, Paramasivam S, Ren J, Al-Khalil T, et al. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. J Virol Methods. 2013;187:406\u201312. https:\/\/doi.org\/10.1016\/j.jviromet.2012.11.011.","journal-title":"J Virol Methods"},{"key":"519_CR88","doi-asserted-by":"publisher","first-page":"e1003255","DOI":"10.1371\/journal.ppat.1003255","volume":"9","author":"C Porta","year":"2013","unstructured":"Porta C, Kotecha A, Burman A, Jackson T, Ren J, Loureiro S, et al. Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. PLoS Pathog. 2013;9:e1003255. https:\/\/doi.org\/10.1371\/journal.ppat.1003255.","journal-title":"PLoS Pathog"},{"key":"519_CR89","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nsmb.3096","volume":"22","author":"A Kotecha","year":"2015","unstructured":"Kotecha A, Seago J, Scott K, Burman A, Loureiro S, Ren J, et al. Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design. Nat Struct Mol Biol. 2015;22:788\u201394. https:\/\/doi.org\/10.1038\/nsmb.3096.","journal-title":"Nat Struct Mol Biol"},{"key":"519_CR90","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2217\/fvl.12.65","volume":"7","author":"MJ Grubman","year":"2012","unstructured":"Grubman MJ, Diaz-San Segundo F, Dias CCA, Moraes MP, Perez-Martin E, de los Santos T. Use of replication-defective adenoviruses to develop vaccines and biotherapeutics against foot-and-mouth disease. Future Virol. 2012;7:767\u201378.","journal-title":"Future Virol."},{"key":"519_CR91","doi-asserted-by":"publisher","first-page":"e0157435","DOI":"10.1371\/journal.pone.0157435","volume":"11","author":"M Gullberg","year":"2016","unstructured":"Gullberg M, Lohse L, B\u00f8tner A, McInerney GM, Burman A, Jackson T, et al. A prime-boost vaccination strategy in cattle to prevent foot-and-mouth disease using a \u201csingle-cycle\u201d alphavirus vector and empty capsid particles. PLoS ONE. 2016;11:e0157435. https:\/\/doi.org\/10.1371\/journal.pone.0157435.","journal-title":"PLoS ONE"},{"key":"519_CR92","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1016\/j.vaccine.2019.08.017","volume":"37","author":"T Sitt","year":"2019","unstructured":"Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, et al. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers. Vaccine. 2019;37:6221\u201331. https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.017.","journal-title":"Vaccine."},{"key":"519_CR93","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1128\/JVI.73.2.1092-1098.1999","volume":"73","author":"C Smerdou","year":"1999","unstructured":"Smerdou C, Liljestr\u00f6m P. Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol. 1999;73:1092\u20138.","journal-title":"J Virol"},{"key":"519_CR94","doi-asserted-by":"publisher","first-page":"11675","DOI":"10.1128\/JVI.01254-12","volume":"86","author":"S Uddowla","year":"2012","unstructured":"Uddowla S, Hollister J, Pacheco JM, Rodriguez LL, Rieder E. A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol. 2012;86:11675\u201385. https:\/\/doi.org\/10.1128\/JVI.01254-12.","journal-title":"J Virol"},{"key":"519_CR95","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1099\/vir.0.052126-0","volume":"94","author":"GJ Belsham","year":"2013","unstructured":"Belsham GJ. Influence of the Leader protein coding region of foot-and-mouth disease virus on virus replication. J Gen Virol. 2013;94:1486\u201395. https:\/\/doi.org\/10.1099\/vir.0.052126-0.","journal-title":"J Gen Virol"}],"container-title":["Acta Veterinaria Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-020-00519-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13028-020-00519-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-020-00519-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:29:18Z","timestamp":1621495758000},"score":1,"resource":{"primary":{"URL":"https:\/\/actavetscand.biomedcentral.com\/articles\/10.1186\/s13028-020-00519-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s13028-020-00519-1","relation":{},"ISSN":["1751-0147"],"issn-type":[{"value":"1751-0147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This review did not require official or institutional ethical approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}